Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$6.18 - $7.99 $15,147 - $19,583
-2,451 Closed
0 $0
Q4 2022

May 09, 2023

BUY
$6.87 - $10.96 $16,838 - $26,862
2,451 New
2,451 $18,000
Q3 2021

Nov 15, 2021

SELL
$15.35 - $21.27 $89,198 - $123,599
-5,811 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $57,058 - $78,124
3,632 Added 166.68%
5,811 $125,000
Q1 2021

May 13, 2021

BUY
$13.42 - $20.28 $29,242 - $44,190
2,179 New
2,179 $33,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $269M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.